newsfilter
← Latest News
GlobeNewswire·

Petros Pharmaceuticals Reports Year End 2021 Financial Results and Corporate Highlights

NEW YORK, April 01, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. ("Petros" or "the Company") (NASDAQ:PTPI), a leading provider of therapeutics for men's health, today announces financial results for the fiscal year ended December 31, 2021.